

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfate transmembrane transport (GO:1902358) | 9.81996016 |
| 2 | sulfate transport (GO:0008272) | 8.20664094 |
| 3 | bicarbonate transport (GO:0015701) | 7.74332661 |
| 4 | intestinal absorption (GO:0050892) | 7.40971164 |
| 5 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 7.20741088 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.15167665 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 7.15167665 |
| 8 | sperm capacitation (GO:0048240) | 7.14468613 |
| 9 | positive regulation of respiratory burst (GO:0060267) | 6.86830656 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.85766321 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 6.85766321 |
| 12 | renal system process involved in regulation of blood volume (GO:0001977) | 6.57423715 |
| 13 | regulation of guanylate cyclase activity (GO:0031282) | 6.55655244 |
| 14 | glucocorticoid biosynthetic process (GO:0006704) | 6.46923576 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 6.41825486 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.36435306 |
| 17 | flavonoid metabolic process (GO:0009812) | 6.34640191 |
| 18 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 5.98274502 |
| 19 | oligosaccharide biosynthetic process (GO:0009312) | 5.97526735 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.80155245 |
| 21 | tryptophan catabolic process (GO:0006569) | 5.79479989 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 5.79479989 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 5.79479989 |
| 24 | kynurenine metabolic process (GO:0070189) | 5.73453127 |
| 25 | positive regulation of fatty acid oxidation (GO:0046321) | 5.66666926 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66224476 |
| 27 | bile acid biosynthetic process (GO:0006699) | 5.55736435 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52689533 |
| 29 | one-carbon metabolic process (GO:0006730) | 5.48364423 |
| 30 | tryptophan metabolic process (GO:0006568) | 5.44300016 |
| 31 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.43916701 |
| 32 | glyoxylate metabolic process (GO:0046487) | 5.41454959 |
| 33 | regulation of intracellular pH (GO:0051453) | 5.37141945 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 5.36148676 |
| 35 | regulation of respiratory burst (GO:0060263) | 5.36116568 |
| 36 | cysteine metabolic process (GO:0006534) | 5.28508560 |
| 37 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.28327139 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 5.22963709 |
| 39 | urea metabolic process (GO:0019627) | 5.14194493 |
| 40 | urea cycle (GO:0000050) | 5.14194493 |
| 41 | regulation of fibrinolysis (GO:0051917) | 5.09833522 |
| 42 | protein carboxylation (GO:0018214) | 5.08892322 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.08892322 |
| 44 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.06606642 |
| 45 | regulation of protein activation cascade (GO:2000257) | 5.03282803 |
| 46 | glomerular filtration (GO:0003094) | 4.98875337 |
| 47 | regulation of cellular pH (GO:0030641) | 4.97808552 |
| 48 | complement activation, alternative pathway (GO:0006957) | 4.94504722 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 4.90872075 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 4.90758085 |
| 51 | bile acid metabolic process (GO:0008206) | 4.90652888 |
| 52 | reverse cholesterol transport (GO:0043691) | 4.83467022 |
| 53 | phospholipid efflux (GO:0033700) | 4.78671070 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 4.74716139 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 4.71697042 |
| 56 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 4.71138393 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 4.70581150 |
| 58 | macromolecular complex remodeling (GO:0034367) | 4.70581150 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 4.70581150 |
| 60 | * bile acid and bile salt transport (GO:0015721) | 4.70174465 |
| 61 | regulation of complement activation (GO:0030449) | 4.69876692 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 4.67374475 |
| 63 | negative regulation of myotube differentiation (GO:0010832) | 4.65708029 |
| 64 | homocysteine metabolic process (GO:0050667) | 4.65489154 |
| 65 | negative regulation of sterol transport (GO:0032372) | 4.64277408 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 4.64277408 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.63158558 |
| 68 | cGMP-mediated signaling (GO:0019934) | 4.62466177 |
| 69 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.61911294 |
| 70 | ethanol metabolic process (GO:0006067) | 4.60907036 |
| 71 | renal filtration (GO:0097205) | 4.54976029 |
| 72 | triglyceride homeostasis (GO:0070328) | 4.53786420 |
| 73 | acylglycerol homeostasis (GO:0055090) | 4.53786420 |
| 74 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.51781143 |
| 75 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.51781143 |
| 76 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.51187480 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 4.50212023 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 4.41454596 |
| 79 | tyrosine metabolic process (GO:0006570) | 4.40313795 |
| 80 | desmosome organization (GO:0002934) | 4.38432806 |
| 81 | sulfur compound transport (GO:0072348) | 4.38099214 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 4.37849559 |
| 83 | alpha-amino acid catabolic process (GO:1901606) | 4.37035248 |
| 84 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.34057801 |
| 85 | endocrine process (GO:0050886) | 4.34057801 |
| 86 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.34057801 |
| 87 | lysine metabolic process (GO:0006553) | 4.32414635 |
| 88 | lysine catabolic process (GO:0006554) | 4.32414635 |
| 89 | regulation of pH (GO:0006885) | 4.27381329 |
| 90 | cellular glucuronidation (GO:0052695) | 4.24910241 |
| 91 | glycine metabolic process (GO:0006544) | 4.20501352 |
| 92 | labyrinthine layer development (GO:0060711) | 4.18674428 |
| 93 | ethanol oxidation (GO:0006069) | 4.15193949 |
| 94 | cholesterol efflux (GO:0033344) | 4.12217604 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 4.10745382 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 4.08188342 |
| 97 | phospholipid homeostasis (GO:0055091) | 4.04504845 |
| 98 | coenzyme catabolic process (GO:0009109) | 4.04496156 |
| 99 | imidazole-containing compound metabolic process (GO:0052803) | 4.03792071 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 4.03625892 |
| 101 | cellular response to pH (GO:0071467) | 4.02058464 |
| 102 | nucleoside diphosphate biosynthetic process (GO:0009133) | 4.01321407 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 3.99970051 |
| 104 | amine catabolic process (GO:0009310) | 3.99682289 |
| 105 | cellular biogenic amine catabolic process (GO:0042402) | 3.99682289 |
| 106 | glutamate metabolic process (GO:0006536) | 3.99366489 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 3.99315704 |
| 108 | benzene-containing compound metabolic process (GO:0042537) | 3.98450513 |
| 109 | regulation of cGMP biosynthetic process (GO:0030826) | 3.95557598 |
| 110 | drug catabolic process (GO:0042737) | 3.93911651 |
| 111 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91068710 |
| 112 | serine family amino acid biosynthetic process (GO:0009070) | 3.88532922 |
| 113 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.84747221 |
| 114 | positive regulation of pseudopodium assembly (GO:0031274) | 3.84185011 |
| 115 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.83697658 |
| 116 | fibrinolysis (GO:0042730) | 3.83144692 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82146475 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82146475 |
| 119 | ketone body metabolic process (GO:1902224) | 3.81678319 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.80518748 |
| 121 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 3.77548414 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.76345336 |
| 123 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.76239056 |
| 124 | transcytosis (GO:0045056) | 3.76099935 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.75201753 |
| 126 | glucuronate metabolic process (GO:0019585) | 3.75201753 |
| 127 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74262659 |
| 128 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.74171378 |
| 129 | response to food (GO:0032094) | 3.72804076 |
| 130 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72642049 |
| 131 | actin filament depolymerization (GO:0030042) | 3.72454783 |
| 132 | regulation of cholesterol homeostasis (GO:2000188) | 3.71714698 |
| 133 | positive regulation of lipid catabolic process (GO:0050996) | 3.71437213 |
| 134 | sterol homeostasis (GO:0055092) | 3.70406942 |
| 135 | arginine metabolic process (GO:0006525) | 3.69719099 |
| 136 | excretion (GO:0007588) | 3.69354367 |
| 137 | O-glycan processing (GO:0016266) | 3.68143357 |
| 138 | monovalent inorganic cation homeostasis (GO:0055067) | 3.67910407 |
| 139 | opsonization (GO:0008228) | 3.67571585 |
| 140 | blood coagulation, intrinsic pathway (GO:0007597) | 3.63793979 |
| 141 | aldehyde catabolic process (GO:0046185) | 3.63732128 |
| 142 | protein-lipid complex assembly (GO:0065005) | 3.63418195 |
| 143 | regulation of systemic arterial blood pressure (GO:0003073) | 3.62913926 |
| 144 | phenylpropanoid metabolic process (GO:0009698) | 3.62460664 |
| 145 | negative regulation of lipase activity (GO:0060192) | 3.62410013 |
| 146 | organic acid catabolic process (GO:0016054) | 3.61952922 |
| 147 | carboxylic acid catabolic process (GO:0046395) | 3.61952922 |
| 148 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.59257106 |
| 149 | response to acidic pH (GO:0010447) | 3.58392417 |
| 150 | plasma lipoprotein particle organization (GO:0071827) | 3.56789560 |
| 151 | acetyl-CoA metabolic process (GO:0006084) | 3.56220718 |
| 152 | thrombin receptor signaling pathway (GO:0070493) | 3.56086182 |
| 153 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.53173924 |
| 154 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.53173924 |
| 155 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.53173924 |
| 156 | protein activation cascade (GO:0072376) | 3.52781766 |
| 157 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.52578478 |
| 158 | intestinal cholesterol absorption (GO:0030299) | 3.52402081 |
| 159 | complement activation, classical pathway (GO:0006958) | 3.51171311 |
| 160 | glucocorticoid metabolic process (GO:0008211) | 3.50848781 |
| 161 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.50403236 |
| 162 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.50403236 |
| 163 | digestive system process (GO:0022600) | 3.49268511 |
| 164 | NAD biosynthetic process (GO:0009435) | 3.48503469 |
| 165 | acute-phase response (GO:0006953) | 3.47148428 |
| 166 | regulation of pseudopodium assembly (GO:0031272) | 3.43521111 |
| 167 | sodium ion homeostasis (GO:0055078) | 3.43352064 |
| 168 | drug transmembrane transport (GO:0006855) | 3.41695176 |
| 169 | regulation of fatty acid oxidation (GO:0046320) | 3.31945597 |
| 170 | GDP-mannose metabolic process (GO:0019673) | 3.31191942 |
| 171 | fucosylation (GO:0036065) | 3.30433129 |
| 172 | intermediate filament organization (GO:0045109) | 3.29227213 |
| 173 | regulation of cGMP metabolic process (GO:0030823) | 3.25301944 |
| 174 | intestinal epithelial cell development (GO:0060576) | 3.23637600 |
| 175 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.21535370 |
| 176 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.21094411 |
| 177 | regulation of viral release from host cell (GO:1902186) | 3.18052966 |
| 178 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.13071746 |
| 179 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08977306 |
| 180 | membrane hyperpolarization (GO:0060081) | 3.05101024 |
| 181 | auditory receptor cell differentiation (GO:0042491) | 3.04192742 |
| 182 | drug transport (GO:0015893) | 3.02077947 |
| 183 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.01684419 |
| 184 | inorganic anion transmembrane transport (GO:0098661) | 2.97530452 |
| 185 | chloride transmembrane transport (GO:1902476) | 2.96513092 |
| 186 | regulation of protein glycosylation (GO:0060049) | 2.96391145 |
| 187 | response to pH (GO:0009268) | 2.95927712 |
| 188 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.93321357 |
| 189 | epoxygenase P450 pathway (GO:0019373) | 2.89543612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.01488378 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.00411362 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.62876914 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20208216 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.92322345 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77901239 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.74154084 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73433956 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.67048237 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.49247778 |
| 11 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.53472327 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.46733980 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.46222792 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.27636654 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07205440 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5269391 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92841641 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89496922 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83625628 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.83384822 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78763284 |
| 22 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.73767012 |
| 23 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.62458864 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.56040525 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55908017 |
| 26 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54583531 |
| 27 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.48924701 |
| 28 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48274560 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43626592 |
| 30 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42918452 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38153723 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.38070616 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36841287 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35641480 |
| 35 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34586061 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29189293 |
| 37 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.29016536 |
| 38 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28706336 |
| 39 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.28511331 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27841553 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27519004 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25203420 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24514221 |
| 44 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.24155791 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21646214 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21512562 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20026746 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17136671 |
| 49 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15221771 |
| 50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14714610 |
| 51 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14301324 |
| 52 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10989959 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06784396 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05026147 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02764245 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02338269 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00180526 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99315513 |
| 59 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99221329 |
| 60 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98322453 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98215806 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97578194 |
| 63 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95844872 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95408914 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94666724 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94572827 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94555829 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93939515 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91026733 |
| 70 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.89487557 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89222079 |
| 72 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86613153 |
| 73 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.85771159 |
| 74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84364750 |
| 75 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84329934 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84305698 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84042127 |
| 78 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82646627 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81709729 |
| 80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81507858 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81260426 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81219754 |
| 83 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80966246 |
| 84 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79185514 |
| 85 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79037132 |
| 86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78789822 |
| 87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78637488 |
| 88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77263483 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76478245 |
| 90 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.76415495 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75695920 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74562177 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74510768 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74000123 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73626950 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72885693 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71982662 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71724320 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71658579 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71290497 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70539802 |
| 102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69897932 |
| 103 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69236547 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68961086 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68789809 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67278728 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67160293 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66399021 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66386793 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65797672 |
| 111 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.64898283 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.64601731 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63401012 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63401012 |
| 115 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62948099 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61439051 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61077564 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.60872195 |
| 119 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59685056 |
| 120 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.57005804 |
| 121 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.56373945 |
| 122 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55947077 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.55606816 |
| 124 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53245154 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52156631 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.51710918 |
| 127 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49673623 |
| 128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48703284 |
| 129 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.47851829 |
| 130 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.47112273 |
| 131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.46679133 |
| 132 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46525237 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45629481 |
| 134 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.45628499 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45018834 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.44828978 |
| 137 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.44219748 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.44057365 |
| 139 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.43858132 |
| 140 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.43643108 |
| 141 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.42257949 |
| 142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41793557 |
| 143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.40459545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.10648760 |
| 2 | MP0005360_urolithiasis | 6.96512756 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.28669533 |
| 4 | MP0005365_abnormal_bile_salt | 6.07960251 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19245142 |
| 6 | MP0004043_abnormal_pH_regulation | 5.18179989 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.31516800 |
| 8 | MP0003866_abnormal_defecation | 4.06955904 |
| 9 | MP0003252_abnormal_bile_duct | 3.88386784 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 3.83952086 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.52630593 |
| 12 | MP0009840_abnormal_foam_cell | 3.20569914 |
| 13 | MP0005083_abnormal_biliary_tract | 3.14611084 |
| 14 | MP0001666_abnormal_nutrient_absorption | 3.11375089 |
| 15 | MP0001663_abnormal_digestive_system | 2.98419245 |
| 16 | MP0000490_abnormal_crypts_of | 2.72623940 |
| 17 | MP0000477_abnormal_intestine_morphology | 2.63061935 |
| 18 | MP0005381_digestive/alimentary_phenotyp | 2.60821245 |
| 19 | MP0005332_abnormal_amino_acid | 2.54909153 |
| 20 | MP0004147_increased_porphyrin_level | 2.44264855 |
| 21 | MP0009379_abnormal_foot_pigmentation | 2.38748085 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.38671241 |
| 23 | MP0003195_calcinosis | 2.35937456 |
| 24 | MP0001664_abnormal_digestion | 2.35590901 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.34591989 |
| 26 | MP0001873_stomach_inflammation | 2.31600243 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.25717975 |
| 28 | MP0000609_abnormal_liver_physiology | 2.06517453 |
| 29 | * MP0002118_abnormal_lipid_homeostasis | 2.05889247 |
| 30 | MP0003868_abnormal_feces_composition | 2.03447415 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.82319792 |
| 32 | MP0002009_preneoplasia | 1.81425308 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.79795622 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.74152115 |
| 35 | MP0005451_abnormal_body_composition | 1.56486703 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53089395 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.46502485 |
| 38 | MP0000467_abnormal_esophagus_morphology | 1.46436294 |
| 39 | MP0002098_abnormal_vibrissa_morphology | 1.45735430 |
| 40 | MP0001764_abnormal_homeostasis | 1.43433627 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.38415079 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.35477920 |
| 43 | MP0003303_peritoneal_inflammation | 1.33051291 |
| 44 | MP0003693_abnormal_embryo_hatching | 1.31385776 |
| 45 | MP0000462_abnormal_digestive_system | 1.30672367 |
| 46 | MP0000604_amyloidosis | 1.28806066 |
| 47 | MP0003011_delayed_dark_adaptation | 1.28230297 |
| 48 | MP0009697_abnormal_copulation | 1.27548636 |
| 49 | MP0005501_abnormal_skin_physiology | 1.22336535 |
| 50 | MP0002254_reproductive_system_inflammat | 1.21377973 |
| 51 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21304751 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.17738604 |
| 53 | MP0003186_abnormal_redox_activity | 1.12716133 |
| 54 | MP0005409_darkened_coat_color | 1.11850371 |
| 55 | MP0000598_abnormal_liver_morphology | 1.10754983 |
| 56 | MP0009053_abnormal_anal_canal | 1.10317432 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.09311956 |
| 58 | MP0005647_abnormal_sex_gland | 1.09310414 |
| 59 | MP0005310_abnormal_salivary_gland | 1.07709144 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.07567457 |
| 61 | MP0000566_synostosis | 1.07378837 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.04156837 |
| 63 | MP0000470_abnormal_stomach_morphology | 1.00677537 |
| 64 | MP0003879_abnormal_hair_cell | 0.96877403 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 0.96577504 |
| 66 | MP0002166_altered_tumor_susceptibility | 0.94425650 |
| 67 | MP0009764_decreased_sensitivity_to | 0.94148334 |
| 68 | MP0002822_catalepsy | 0.94051831 |
| 69 | MP0005257_abnormal_intraocular_pressure | 0.92612440 |
| 70 | MP0002006_tumorigenesis | 0.90231857 |
| 71 | MP0002132_abnormal_respiratory_system | 0.89157926 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.88656812 |
| 73 | MP0009785_altered_susceptibility_to | 0.87798714 |
| 74 | MP0009763_increased_sensitivity_to | 0.86734415 |
| 75 | MP0003329_amyloid_beta_deposits | 0.84818977 |
| 76 | MP0005165_increased_susceptibility_to | 0.84515925 |
| 77 | * MP0009642_abnormal_blood_homeostasis | 0.84477147 |
| 78 | MP0005408_hypopigmentation | 0.82561186 |
| 79 | MP0010678_abnormal_skin_adnexa | 0.82171392 |
| 80 | MP0001849_ear_inflammation | 0.82107917 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.81682524 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.80809729 |
| 83 | MP0001756_abnormal_urination | 0.80752678 |
| 84 | MP0008469_abnormal_protein_level | 0.80599375 |
| 85 | MP0001727_abnormal_embryo_implantation | 0.80280557 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.79091204 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.79074169 |
| 88 | MP0001188_hyperpigmentation | 0.78306146 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.75664291 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.75048055 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.72239874 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.71925334 |
| 93 | MP0004484_altered_response_of | 0.69964572 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.69891533 |
| 95 | MP0008004_abnormal_stomach_pH | 0.69867775 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.69100392 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.68183579 |
| 98 | MP0001661_extended_life_span | 0.67239136 |
| 99 | MP0000377_abnormal_hair_follicle | 0.66090758 |
| 100 | MP0005670_abnormal_white_adipose | 0.64367269 |
| 101 | MP0006035_abnormal_mitochondrial_morpho | 0.63400190 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.63362555 |
| 103 | MP0002796_impaired_skin_barrier | 0.62546237 |
| 104 | MP0002971_abnormal_brown_adipose | 0.62302518 |
| 105 | MP0005334_abnormal_fat_pad | 0.62130423 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.60121581 |
| 107 | MP0004130_abnormal_muscle_cell | 0.59371764 |
| 108 | MP0005266_abnormal_metabolism | 0.58631223 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.57570824 |
| 110 | MP0005025_abnormal_response_to | 0.56749118 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.55976983 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.54917963 |
| 113 | MP0005448_abnormal_energy_balance | 0.54418982 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.53743992 |
| 115 | MP0003283_abnormal_digestive_organ | 0.53730293 |
| 116 | MP0004264_abnormal_extraembryonic_tissu | 0.52943246 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.51703105 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.51321578 |
| 119 | MP0003690_abnormal_glial_cell | 0.51233733 |
| 120 | MP0002932_abnormal_joint_morphology | 0.50453542 |
| 121 | MP0002277_abnormal_respiratory_mucosa | 0.50260394 |
| 122 | MP0009115_abnormal_fat_cell | 0.50255536 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.50071320 |
| 124 | MP0002148_abnormal_hypersensitivity_rea | 0.48828615 |
| 125 | MP0005535_abnormal_body_temperature | 0.48174418 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.48150696 |
| 127 | MP0003045_fibrosis | 0.44814286 |
| 128 | MP0009672_abnormal_birth_weight | 0.44783503 |
| 129 | MP0005595_abnormal_vascular_smooth | 0.44070818 |
| 130 | MP0005395_other_phenotype | 0.43998932 |
| 131 | MP0008873_increased_physiological_sensi | 0.43988420 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.43749105 |
| 133 | MP0003953_abnormal_hormone_level | 0.43491937 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.43000567 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.42602224 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.41987763 |
| 137 | MP0000613_abnormal_salivary_gland | 0.41615205 |
| 138 | MP0002928_abnormal_bile_duct | 0.39760887 |
| 139 | MP0003718_maternal_effect | 0.39716607 |
| 140 | MP0004883_abnormal_blood_vessel | 0.39097012 |
| 141 | MP0005166_decreased_susceptibility_to | 0.39032280 |
| 142 | MP0008872_abnormal_physiological_respon | 0.38993711 |
| 143 | MP0008874_decreased_physiological_sensi | 0.37632021 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.36368451 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.35908198 |
| 146 | MP0000249_abnormal_blood_vessel | 0.34958527 |
| 147 | MP0005164_abnormal_response_to | 0.34552758 |
| 148 | MP0001881_abnormal_mammary_gland | 0.33761522 |
| 149 | MP0004947_skin_inflammation | 0.33193415 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.32194584 |
| 151 | MP0003075_altered_response_to | 0.31950321 |
| 152 | MP0002060_abnormal_skin_morphology | 0.31652639 |
| 153 | MP0006082_CNS_inflammation | 0.30862949 |
| 154 | MP0003436_decreased_susceptibility_to | 0.30563686 |
| 155 | MP0002168_other_aberrant_phenotype | 0.29811093 |
| 156 | MP0001243_abnormal_dermal_layer | 0.29692945 |
| 157 | MP0003724_increased_susceptibility_to | 0.29678391 |
| 158 | MP0001845_abnormal_inflammatory_respons | 0.28970838 |
| 159 | MP0003453_abnormal_keratinocyte_physiol | 0.27452403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 8.91898559 |
| 2 | Abnormality of renin-angiotensin system (HP:0000847) | 8.90999520 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.20096805 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 7.13142653 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 6.97546202 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.91903900 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.40164852 |
| 8 | Flat acetabular roof (HP:0003180) | 6.39550797 |
| 9 | Hyperaldosteronism (HP:0000859) | 6.31783234 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 6.27111056 |
| 11 | Xanthomatosis (HP:0000991) | 6.20198119 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 6.07624150 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 5.75123835 |
| 14 | Hyponatremia (HP:0002902) | 5.42206117 |
| 15 | Hypokalemia (HP:0002900) | 4.88580106 |
| 16 | Complement deficiency (HP:0004431) | 4.82383114 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.75456430 |
| 18 | Neonatal short-limb short stature (HP:0008921) | 4.59282112 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46892325 |
| 20 | Abnormality of potassium homeostasis (HP:0011042) | 4.44180708 |
| 21 | Hyperglycinemia (HP:0002154) | 4.40755025 |
| 22 | Flat capital femoral epiphysis (HP:0003370) | 4.40321107 |
| 23 | Joint hemorrhage (HP:0005261) | 4.40006007 |
| 24 | Hyperammonemia (HP:0001987) | 4.38746577 |
| 25 | Flattened epiphyses (HP:0003071) | 4.31531009 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.20425648 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.12145028 |
| 28 | Abdominal distention (HP:0003270) | 4.10482035 |
| 29 | Fat malabsorption (HP:0002630) | 4.10309356 |
| 30 | Abnormality of sodium homeostasis (HP:0010931) | 4.09042372 |
| 31 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.06998178 |
| 32 | Epidermoid cyst (HP:0200040) | 4.05510757 |
| 33 | Hypoglycemic coma (HP:0001325) | 4.02203777 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 3.97314976 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96671407 |
| 36 | Ketosis (HP:0001946) | 3.93660921 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90398304 |
| 38 | Hyperglycinuria (HP:0003108) | 3.88775093 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.84764959 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.79663386 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.79663386 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74943769 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 3.68633310 |
| 44 | Hyperkalemia (HP:0002153) | 3.62792992 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61056440 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.58064828 |
| 47 | Abnormality of complement system (HP:0005339) | 3.49162807 |
| 48 | Spinal cord compression (HP:0002176) | 3.41240263 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.32038770 |
| 50 | Malnutrition (HP:0004395) | 3.31503717 |
| 51 | Adrenal overactivity (HP:0002717) | 3.30048922 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28437614 |
| 53 | Hyperbilirubinemia (HP:0002904) | 3.27432837 |
| 54 | Visceral angiomatosis (HP:0100761) | 3.26217330 |
| 55 | Breech presentation (HP:0001623) | 3.19920305 |
| 56 | Ileus (HP:0002595) | 3.17921791 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17316230 |
| 58 | Steatorrhea (HP:0002570) | 3.03798786 |
| 59 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.96409453 |
| 60 | Vertebral hypoplasia (HP:0008417) | 2.96409453 |
| 61 | Hemangiomatosis (HP:0007461) | 2.94311093 |
| 62 | Pili torti (HP:0003777) | 2.92589994 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.89604237 |
| 64 | Spontaneous abortion (HP:0005268) | 2.88750445 |
| 65 | Myocardial infarction (HP:0001658) | 2.88073702 |
| 66 | Ketoacidosis (HP:0001993) | 2.85627995 |
| 67 | Vertebral clefting (HP:0008428) | 2.84368699 |
| 68 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.83804133 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 2.81900236 |
| 70 | Irregular epiphyses (HP:0010582) | 2.77265936 |
| 71 | Abnormal cartilage morphology (HP:0002763) | 2.76528916 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.76318519 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.73956008 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73956008 |
| 75 | Large earlobe (HP:0009748) | 2.72660086 |
| 76 | Abnormal vertebral ossification (HP:0100569) | 2.70661218 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.69929791 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.68386970 |
| 79 | Metabolic acidosis (HP:0001942) | 2.59694395 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.59002409 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 2.56512220 |
| 82 | Skin nodule (HP:0200036) | 2.55384003 |
| 83 | Syncope (HP:0001279) | 2.55328592 |
| 84 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.54423892 |
| 85 | Vascular calcification (HP:0004934) | 2.53623801 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.50059187 |
| 87 | Abnormality of carpal bone ossification (HP:0006257) | 2.48684233 |
| 88 | Glomerulonephritis (HP:0000099) | 2.47983939 |
| 89 | Acanthocytosis (HP:0001927) | 2.47422037 |
| 90 | Abnormality of the 1st metacarpal (HP:0010009) | 2.45779689 |
| 91 | Lethargy (HP:0001254) | 2.45388530 |
| 92 | Spastic diplegia (HP:0001264) | 2.43445919 |
| 93 | Dehydration (HP:0001944) | 2.43082085 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.42092960 |
| 95 | Cholecystitis (HP:0001082) | 2.42092960 |
| 96 | Gout (HP:0001997) | 2.40015712 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.39365173 |
| 98 | Esophageal varix (HP:0002040) | 2.39193145 |
| 99 | Abnormal biliary tract morphology (HP:0012440) | 2.38248947 |
| 100 | Abnormal hair laboratory examination (HP:0003328) | 2.37610898 |
| 101 | Late onset (HP:0003584) | 2.33847752 |
| 102 | Cholelithiasis (HP:0001081) | 2.33297288 |
| 103 | Irritability (HP:0000737) | 2.30190578 |
| 104 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.27297628 |
| 105 | Villous atrophy (HP:0011473) | 2.27297628 |
| 106 | Pancreatitis (HP:0001733) | 2.26344079 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.26088711 |
| 108 | Increased density of long bones (HP:0006392) | 2.25509246 |
| 109 | Generalized aminoaciduria (HP:0002909) | 2.21816468 |
| 110 | Renal tubular acidosis (HP:0001947) | 2.18402837 |
| 111 | Petechiae (HP:0000967) | 2.16825844 |
| 112 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16800463 |
| 113 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.16440203 |
| 114 | Amyloidosis (HP:0011034) | 2.15249803 |
| 115 | Cerebral edema (HP:0002181) | 2.11801373 |
| 116 | Gingival bleeding (HP:0000225) | 2.11170317 |
| 117 | Mitral stenosis (HP:0001718) | 2.09741481 |
| 118 | Neonatal onset (HP:0003623) | 2.09589995 |
| 119 | Menorrhagia (HP:0000132) | 2.08241494 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 2.07683137 |
| 121 | Chronic bronchitis (HP:0004469) | 2.06006752 |
| 122 | Hemorrhage of the eye (HP:0011885) | 2.04529017 |
| 123 | Abnormal foot bone ossification (HP:0010675) | 2.04285953 |
| 124 | Hoarse voice (HP:0001609) | 2.03575013 |
| 125 | Short middle phalanx of finger (HP:0005819) | 2.03043396 |
| 126 | Vomiting (HP:0002013) | 2.02045312 |
| 127 | Hyperactive renin-angiotensin system (HP:0000841) | 12.1415113 |
| 128 | Metabolic alkalosis (HP:0200114) | 10.6077159 |
| 129 | Hyperparathyroidism (HP:0000843) | 1.99719031 |
| 130 | Alkalosis (HP:0001948) | 1.99291327 |
| 131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98724714 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 1.98268862 |
| 133 | Palpitations (HP:0001962) | 1.95592327 |
| 134 | Brushfield spots (HP:0001088) | 1.95043334 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.94645468 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.94645468 |
| 137 | Thrombophlebitis (HP:0004418) | 1.94155963 |
| 138 | Poikilocytosis (HP:0004447) | 1.93716287 |
| 139 | Abnormal tarsal ossification (HP:0008369) | 1.93418558 |
| 140 | Bundle branch block (HP:0011710) | 1.93231540 |
| 141 | Rickets (HP:0002748) | 1.91863155 |
| 142 | Abnormal hand bone ossification (HP:0010660) | 1.90038702 |
| 143 | Renal cortical cysts (HP:0000803) | 1.89996468 |
| 144 | Enlarged kidneys (HP:0000105) | 1.88435255 |
| 145 | Abnormal ossification of hand bones (HP:0005921) | 1.87128196 |
| 146 | Glycosuria (HP:0003076) | 1.86787419 |
| 147 | Abnormality of urine glucose concentration (HP:0011016) | 1.86787419 |
| 148 | Cone-rod dystrophy (HP:0000548) | 1.86317085 |
| 149 | Hip contracture (HP:0003273) | 1.85652568 |
| 150 | Opisthotonus (HP:0002179) | 1.84850550 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84187136 |
| 152 | Symptomatic seizures (HP:0011145) | 1.83918678 |
| 153 | Short phalanx of the thumb (HP:0009660) | 1.83076031 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.82665831 |
| 155 | Hyperglycemia (HP:0003074) | 1.82456952 |
| 156 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82407622 |
| 157 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76732552 |
| 158 | Increased purine levels (HP:0004368) | 1.76038078 |
| 159 | Biliary tract neoplasm (HP:0100574) | 1.75531423 |
| 160 | Amelogenesis imperfecta (HP:0000705) | 1.75394916 |
| 161 | Curly hair (HP:0002212) | 1.75240435 |
| 162 | Thin bony cortex (HP:0002753) | 1.74344070 |
| 163 | Renal salt wasting (HP:0000127) | 1.70335319 |
| 164 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.69296835 |
| 165 | Severe short stature (HP:0003510) | 1.68518142 |
| 166 | Chronic diarrhea (HP:0002028) | 1.66872409 |
| 167 | Cerebral hemorrhage (HP:0001342) | 1.66341583 |
| 168 | Abnormality of the acetabulum (HP:0003170) | 1.64087864 |
| 169 | Stillbirth (HP:0003826) | 1.63018521 |
| 170 | Hip dysplasia (HP:0001385) | 1.60527587 |
| 171 | Hypotension (HP:0002615) | 1.59761249 |
| 172 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.58715770 |
| 173 | Cupped ribs (HP:0000887) | 1.55675179 |
| 174 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.55605949 |
| 175 | Abnormality of vitamin B metabolism (HP:0004340) | 1.54760823 |
| 176 | Protuberant abdomen (HP:0001538) | 1.53824449 |
| 177 | Eczematoid dermatitis (HP:0000976) | 1.53080792 |
| 178 | Neoplasm of the rectum (HP:0100743) | 1.49495704 |
| 179 | Bone pain (HP:0002653) | 1.47063635 |
| 180 | Ankle clonus (HP:0011448) | 1.42888828 |
| 181 | Axonal loss (HP:0003447) | 1.42284290 |
| 182 | Growth hormone excess (HP:0000845) | 1.41728617 |
| 183 | Abnormality of vitamin metabolism (HP:0100508) | 1.39937271 |
| 184 | Focal segmental glomerulosclerosis (HP:0000097) | 1.39815080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 9.22004091 |
| 2 | EPHA2 | 5.73908101 |
| 3 | BCKDK | 5.41822458 |
| 4 | ACVR1B | 5.38919408 |
| 5 | LMTK2 | 5.38471812 |
| 6 | MST1R | 4.18785179 |
| 7 | FGFR4 | 3.32473746 |
| 8 | ERN1 | 3.26014560 |
| 9 | SIK1 | 3.11118416 |
| 10 | EPHB2 | 2.41743694 |
| 11 | PIK3CA | 2.41142007 |
| 12 | PKN2 | 1.92296143 |
| 13 | PIK3CG | 1.88854199 |
| 14 | INSRR | 1.84985040 |
| 15 | WNK4 | 1.75524259 |
| 16 | KSR2 | 1.69544605 |
| 17 | MAP3K12 | 1.65659019 |
| 18 | STK24 | 1.64454592 |
| 19 | MET | 1.62241367 |
| 20 | TRIB3 | 1.58921991 |
| 21 | MAP2K2 | 1.58887813 |
| 22 | TESK2 | 1.57643250 |
| 23 | RIPK1 | 1.57283655 |
| 24 | TESK1 | 1.54977641 |
| 25 | ERBB4 | 1.49539439 |
| 26 | MAP3K2 | 1.49240004 |
| 27 | STK39 | 1.48590686 |
| 28 | PTK6 | 1.47846603 |
| 29 | FLT3 | 1.36314908 |
| 30 | MAPK11 | 1.28408371 |
| 31 | FRK | 1.21885979 |
| 32 | MAP2K4 | 1.18735887 |
| 33 | RIPK4 | 1.16664612 |
| 34 | GRK6 | 1.12390470 |
| 35 | ABL2 | 1.09422500 |
| 36 | KDR | 1.08479280 |
| 37 | MAP2K1 | 1.08396747 |
| 38 | TYK2 | 1.07491658 |
| 39 | MYLK | 1.07132995 |
| 40 | LATS1 | 1.02359319 |
| 41 | MAP3K14 | 1.00235434 |
| 42 | CAMK2D | 0.96778730 |
| 43 | DAPK2 | 0.94737545 |
| 44 | PTK2 | 0.91437641 |
| 45 | OXSR1 | 0.88161874 |
| 46 | PRKAA2 | 0.84889193 |
| 47 | JAK2 | 0.84866966 |
| 48 | ICK | 0.84146592 |
| 49 | FGFR2 | 0.83222817 |
| 50 | MST4 | 0.81451753 |
| 51 | MAP3K7 | 0.78754657 |
| 52 | TBK1 | 0.77623162 |
| 53 | TGFBR2 | 0.75116808 |
| 54 | DDR2 | 0.74658502 |
| 55 | ERBB2 | 0.71583600 |
| 56 | PAK4 | 0.70795904 |
| 57 | PRKCZ | 0.68837492 |
| 58 | NEK9 | 0.68296118 |
| 59 | PRPF4B | 0.66511759 |
| 60 | MAP2K3 | 0.66202509 |
| 61 | MAP3K1 | 0.66114569 |
| 62 | MAP3K3 | 0.63542760 |
| 63 | MAP3K10 | 0.63295265 |
| 64 | EPHB1 | 0.59096905 |
| 65 | MAP3K13 | 0.57941978 |
| 66 | TAOK1 | 0.57702064 |
| 67 | TIE1 | 0.57088395 |
| 68 | MAPK4 | 0.55126864 |
| 69 | PDPK1 | 0.53699978 |
| 70 | JAK1 | 0.53026269 |
| 71 | PRKACG | 0.52897519 |
| 72 | MAP3K11 | 0.52860843 |
| 73 | CSK | 0.52747075 |
| 74 | MAPK12 | 0.52334106 |
| 75 | RET | 0.51051615 |
| 76 | PRKCI | 0.50619726 |
| 77 | MATK | 0.49801688 |
| 78 | MAPK15 | 0.48859291 |
| 79 | CAMK2G | 0.48038573 |
| 80 | NME1 | 0.44986583 |
| 81 | SMG1 | 0.44306140 |
| 82 | PRKAA1 | 0.43308855 |
| 83 | CDK6 | 0.42246769 |
| 84 | GSK3A | 0.40841236 |
| 85 | MAP2K6 | 0.40815382 |
| 86 | CSNK1A1 | 0.40742825 |
| 87 | TNIK | 0.39828210 |
| 88 | RPS6KA2 | 0.39220280 |
| 89 | ARAF | 0.38989768 |
| 90 | DYRK1B | 0.38970453 |
| 91 | EPHA3 | 0.37171364 |
| 92 | MAP3K8 | 0.36214424 |
| 93 | MAPKAPK2 | 0.35248428 |
| 94 | STK38L | 0.34683002 |
| 95 | SRC | 0.34357515 |
| 96 | PRKCQ | 0.33902264 |
| 97 | CDK4 | 0.33856394 |
| 98 | FER | 0.33748132 |
| 99 | MTOR | 0.33625103 |
| 100 | NME2 | 0.33258272 |
| 101 | TAOK2 | 0.32793408 |
| 102 | PDK1 | 0.32677511 |
| 103 | PHKG2 | 0.32242472 |
| 104 | PHKG1 | 0.32242472 |
| 105 | IGF1R | 0.32060413 |
| 106 | CDC42BPA | 0.31956978 |
| 107 | DMPK | 0.30195084 |
| 108 | PDK2 | 0.29804510 |
| 109 | PINK1 | 0.29488824 |
| 110 | PRKG2 | 0.29459698 |
| 111 | CDK19 | 0.28883375 |
| 112 | LATS2 | 0.27677671 |
| 113 | PDK3 | 0.27423090 |
| 114 | PDK4 | 0.27423090 |
| 115 | CAMK1D | 0.27422621 |
| 116 | PTK2B | 0.26898699 |
| 117 | WNK1 | 0.26594681 |
| 118 | PDGFRA | 0.26149962 |
| 119 | IKBKE | 0.24520349 |
| 120 | PRKCA | 0.23074156 |
| 121 | SGK494 | 0.21232932 |
| 122 | SGK223 | 0.21232932 |
| 123 | EPHA4 | 0.19987570 |
| 124 | ITK | 0.19675199 |
| 125 | MAPK7 | 0.19621498 |
| 126 | FGFR1 | 0.19071714 |
| 127 | GRK1 | 0.18834390 |
| 128 | LYN | 0.18726863 |
| 129 | DAPK3 | 0.18566046 |
| 130 | BMX | 0.18071147 |
| 131 | NEK1 | 0.17338783 |
| 132 | ZAP70 | 0.17261092 |
| 133 | PAK2 | 0.17190547 |
| 134 | EGFR | 0.16657873 |
| 135 | MAPKAPK3 | 0.16639393 |
| 136 | PIM2 | 0.16384092 |
| 137 | YES1 | 0.16348632 |
| 138 | SGK3 | 0.16244256 |
| 139 | CSNK1G1 | 0.16187308 |
| 140 | RPS6KC1 | 0.15154194 |
| 141 | RPS6KL1 | 0.15154194 |
| 142 | ROCK1 | 0.14751655 |
| 143 | EEF2K | 0.10974420 |
| 144 | CDK9 | 0.10220578 |
| 145 | FGFR3 | 0.09209449 |
| 146 | FYN | 0.09142372 |
| 147 | RPS6KA6 | 0.08593301 |
| 148 | PRKCD | 0.07844582 |
| 149 | STK38 | 0.07596875 |
| 150 | PRKCB | 0.06342480 |
| 151 | LRRK2 | 0.06119722 |
| 152 | MAP4K1 | 0.05726926 |
| 153 | RPS6KB1 | 0.05455862 |
| 154 | NEK6 | 0.05319943 |
| 155 | ILK | 0.04821504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26702212 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47010294 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43605792 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.06690684 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06296653 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84381278 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70296722 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63093236 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62928400 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62029566 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46781964 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44902571 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40485876 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28114916 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17176827 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12652440 |
| 17 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.06088090 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01484843 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00720849 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00632979 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00572128 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.96029912 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92939734 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92294733 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85094969 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84346499 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83625353 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.77958408 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71062191 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67405697 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66871025 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66851949 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65723297 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59932903 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57526992 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55035594 |
| 37 | * Bile secretion_Homo sapiens_hsa04976 | 1.53118034 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44035421 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43189878 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42644887 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41077285 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40890232 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.39823496 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31302483 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30853719 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29698218 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23429628 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20882443 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19189451 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.15422886 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13975921 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13501521 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12550821 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97532431 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96269471 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96086907 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94817302 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92534294 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89555958 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84820705 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84580733 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83892240 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80209888 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.79628816 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79167859 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78556104 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76790051 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76585457 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.70338511 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67951700 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64452741 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52371113 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49602019 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48770068 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47594081 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.46631601 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44028137 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39905299 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.33827220 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32634278 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26179078 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23484095 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21912649 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21823383 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20310853 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.18367434 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18073840 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18042361 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.17329828 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15791812 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15302743 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14774733 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.13507418 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.13429310 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10357684 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.09628859 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07480105 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.06917195 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.04389481 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.03526988 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03314605 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.02151223 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00975792 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00517723 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1826315 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1769248 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1556657 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1371421 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1343342 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | -0.1315821 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1270942 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1239462 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1223426 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.1206846 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | -0.1099583 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1039500 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0999857 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0988874 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0887929 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | -0.0715837 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0695128 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.0682044 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0674753 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0669911 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | -0.0620727 |
| 126 | Pertussis_Homo sapiens_hsa05133 | -0.0561552 |
| 127 | Influenza A_Homo sapiens_hsa05164 | -0.0544518 |
| 128 | Allograft rejection_Homo sapiens_hsa05330 | -0.0534974 |
| 129 | Taste transduction_Homo sapiens_hsa04742 | -0.0476439 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0423845 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0198789 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0186804 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0126498 |

